Molecular Analysis for Precision Oncology Congress 2026

The Molecular Analysis for Precision Oncology Congress 2026 will take place from 10 to 11 September in London, UK, bringing together leading experts in oncology, molecular diagnostics, and precision medicine for two days of high-level exchange, collaboration, and innovation.

Building on the momentum of previous editions, the congress will provide a platform to share advances in cancer research, strengthen connections across disciplines, and accelerate the translation of molecular insights into clinical practice.

Through keynote sessions, discussions, and networking opportunities, participants will engage with the evolving landscape of precision oncology and its impact on patient care worldwide.

Organised by Cancer Research UK (CRUK), the European Society for Medical Oncology (ESMO), and Unicancer, MAP 2026 promises to be a landmark meeting where science, medicine, and collaboration converge to shape the future of oncology.

The Molecular Analysis for Precision Oncology Congress will take place from 10 to 11 September 2026 in London, UK. Congress resources will be available post-event on OncologyPRO.

You will need an ESMO account  to register yourself or a group. 

Registration includes:

• Participation in scientific and educational sessions
• Opportunities to network with speakers, faculty and peers
• Access to the poster area and e-Poster area
• Interaction with the industry partners in the exhibition area
• Participation in the Industry Satellite Symposia
• Access to the meeting resources on OncologyPRO after the event
• The ESMO Daily Reporter
• Coffee breaks and lunches

Registration fees and deadlines

Individual registration will remain open for the duration of the congress. The ESMO Congress Secretariat must receive one completed registration per participant and the corresponding payment in EUR by the given deadlines. 

ESMO membership must be active ten (10) working days prior to the registration, to be eligible for the reduced member registration fee. Please visit membership page on esmo.org to check eligibility criteria, benefits, and to complete the membership application.

MAP focuses on current and emerging approaches in precision oncology, highlights successes and challenges, and proposes potential solutions in clinical research and practice.

Learning Objectives

• Explore advances in the molecular characterisation of cancer, including extrachromosomal DNA biology.
• Understand technologies for cancer interception, early detection, and profiling, including liquid biopsy and multiomic biomarkers.
• Highlight mechanisms underlying tumour progression, immune dynamics, and metastatic dissemination.
• Learn about breakthroughs in epigenetic regulation and molecular mechanisms shaping cancer evolution.